Hi SuperWealthy.
In terms of speculating (on SP movement), this stat is noteworthy:
Healthmatch by comparison (as per the Smartcompany article linked in prior post) launched in 2017 and took 3 years to reach 80k patients. Opyl, with it's marketing savvy/ relationships, achieved this within a year, and without the public launch of Opin.
Meanwhile... Healthmatch is valued on the private market at over 6 times that of the current Opyl SP.
Ann: Opyl - Investor presentation introducing Opin, page-6
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.902M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4500 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 4000 | 1 |
View Market Depth
| Last trade - 16.12pm 18/09/2024 (20 minute delay) ? |
| OPL (ASX) Chart |
Day chart unavailable